New malaria drug shows promise in early human testing
NCT ID NCT05979207
First seen Jan 06, 2026 · Last updated Apr 30, 2026 · Updated 22 times
Summary
This study tested a new experimental malaria drug called MMV367 in 12 healthy adults. Participants were intentionally infected with a controlled dose of malaria parasites in a safe, monitored environment to see how well the drug worked and how safe it was. The goal was to understand the right dose and how the body processes the drug, not to cure anyone—all participants received standard malaria treatment at the end.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
South Bank
Brisbane, Queensland, 4101, Australia
-
USC Clinical Trials, Morayfield
Brisbane, Queensland, 4506, Australia
Conditions
Explore the condition pages connected to this study.